Delivery Order SPE2DB22D1200-SPE2DB24FN4DC

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Fenofibrate 145 mg tablets, a cardiovascular medication, valued at $10,512.99 with a completion date of September 26, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,042.97 fixed-price contract is for the delivery of Fenofibrate 145 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $107,703.25, is for the delivery of Fenofibrate 145 mg tablets over the period ending on April 4, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,595.75, is a delivery order for the supply of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is a firm fixed-price arrangement. This contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,068.36, is for the supply of 4564160110 - Fenofibrate 145 mg tablets in 90-count bottles. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 90-count bottles of 160 mg Fenofibrate tablets, with a total ceiling value of $5,347.01. The contract has an ultimate completion date of May 9, 2023, and uses a firm fixed-price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fenofibrate 160 mg tablets, a cardiovascular medication, and has a ceiling value of $1,702.79. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 20, 2023. This contract is not designated as a set-aside....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglycerides. The contract has a ceiling value of $7,245.44 and a completion date of June 11, 2025. It is a firm-fixed-price contract, which means the price will not change regardless of the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,780.36, is a Delivery Order contract with a Firm Fixed Price pricing type. It covers the supply of 4567104529 FENOFIBRATE 145 MG TABLET 500S, with an Ultimate Completion Date of January 31, 2025. The contract is not designated as a Set-Aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of fenofibrate 145 mg tablets. The ceiling value of this order is $1,072.97. This award was not set aside for a specific business type. AmerisourceBergen is the prime contractor and no subcontractors were mentioned. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, for...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB24FN4DC
    Delivery Order

This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,187.94 firm-fixed-price contract is for the delivery of 500 tablets of Fenofibrate 145 mg, a medication used to treat high cholesterol and triglycerides. The contract has an ultimate completion date of August 9, 2024, and is not designated as a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, for supplying a broad range of pharmaceutical and medical products to support military treatment facilities, veterans' healthcare, and other government healthcare programs nationwide.

Generated 11/7/24, 9:22 AM